Onconova Therapeutics, Inc. Warrants
ONTXW
ONTXW was delisted on the 23rd of July, 2021.
3 hedge funds and large institutions have $5K invested in Onconova Therapeutics, Inc. Warrants in 2020 Q2 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, 0 reducing their positions, and 0 closing their positions.
200% more funds holding
Funds holding: 1 → 3 (+2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$3.48K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$2.02K |
Top Sellers
ONTXW Hedge Fund Activity: Q2 2020 in Review
3 of the 4,888 institutional investors tracked by Wall St. Rank reported a position in Onconova Therapeutics, Inc. Warrants (ONTXW) for Q2 2020, worth a combined $5K.
Buyers outnumbered sellers: 2 funds opened new ONTXW positions and 0 closed out — a net gain of 2 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $3.48K.
- 3 institutional investors held Onconova Therapeutics, Inc. Warrants (ONTXW) as of Q2 2020, up from 1 in Q1 2020.
- Funds reported $5K of Onconova Therapeutics, Inc. Warrants stock for Q2 2020.
- 2 funds opened new Onconova Therapeutics, Inc. Warrants positions in Q2 2020 and 0 closed out, a net change of +2 holders.
- The largest Onconova Therapeutics, Inc. Warrants buyer in Q2 2020 was Citadel Advisors, an estimated $3.48K added.
Based on aggregated 13F filings for Q2 2020.